|
- Rheumatoid Arthritis and Cancer Risk
People with rheumatoid arthritis (RA), and some related inflammatory diseases, face the reality of a slightly increased risk for developing certain types of cancer
- Managing rheumatoid arthritis and cancer: 5 insights
For patients with rheumatoid arthritis who develop cancer, there are several options for treatment, including traditional and biologic therapies that can be used safely without any evidence that they will cause cancer to spread or make recurrences more likely
- The relationships between cancer and autoimmune rheumatic diseases
Similar to SLE and RA, patients with giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) have only a slightly increased risk of cancer A systematic review of cohort studies showed a risk ratio of 1 14 for any malignancy in patients with GCA PMR 30
- Rheumatoid Factor (RF): Cancer Risk and Tests - Health
High RF levels typically occur in people with rheumatoid arthritis (RA), a chronic autoimmune disorder that causes joint pain and swelling You may be at increased risk for certain cancers
- Does Having Arthritis Increase Cancer Risk?
Some treatments for rheumatoid arthritis could increase cancer risk One reason is because some cells in our immune system are trained to find and attack cancer cells
- Cancer risk in rheumatoid arthritis: anything new? | RheumNow
There is still a question I have a hard time answering with certainty when people living with rheumatoid arthritis ask me: Is there a higher risk of cancer that comes with the disease?
- What to Know About RA and Cancer Risk - HealthCentral
Having RA elevates your likelihood of getting cancer, but there are plenty of caveats to know In addition to the pain and fatigue that come with an inflammatory joint disease, having
- What Rheumatologists Need to Know About Cancer Risk in Rheumatoid Arthritis
In the United States, the lifetime risk of developing cancer is 1 in 3 individuals 1 For patients with rheumatoid arthritis (RA), this risk may be increased due to the shared etiology between cancer and RA and the immunomodulatory nature of agents commonly used in RA treatment 2
|
|
|